19.27
BATS BZX Real-Time Price
As of 2:15pm ET
 +0.74 / +4.02%
Today’s Change
16.63
Today|||52-Week Range
39.59
-29.65%
Year-to-Date
Company News For Aug 15, 2019
Aug 15 / Zacks.com - Paid Partner Content
Biopharma Tie-Ups and Quebecois Weed Woes
Aug 12 / MotleyFool.com - Paid Partner Content
Should Value Investors Pick Mylan N.V. (MYL) Stock?
Aug 14 / Zacks.com - Paid Partner Content
Here's What's Pushing Teva Pharmaceutical Industries Stock Even Lower Today
Aug 06 / MotleyFool.com - Paid Partner Content
Amgen Wins Enbrel U.S. Patent Litigation Against Novartis
Aug 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close18.53
Today’s open18.82
Day’s range18.82 - 19.35
Volume2,611,496
Average volume (3 months)8,111,707
Market cap$9.6B
Data as of 2:15pm ET, 08/19/2019

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-6.05%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio319.8
Price/Sales1.24
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...+1.00+1.45%
GLPGGalapagos NV-4.57-2.65%
SRPTSarepta Therapeutics...-2.89-2.31%
ALNYAlnylam Pharmaceutic...+1.69+2.09%
Data as of 2:14pm ET, 08/19/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts